Tibet Rhodiola Pharmaceutical Holding Co (600211)

Currency in CNY
42.40
-0.40(-0.93%)
Closed·
High dividend Yield
600211 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
42.0843.03
52 wk Range
34.6057.98
Key Statistics
Bid/Ask
42.39 / 42.41
Prev. Close
42.8
Open
42.47
Day's Range
42.08-43.03
52 wk Range
34.6-57.98
Volume
2.3M
Average Volume (3m)
3.53M
1-Year Change
17.8105%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600211 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Tibet Rhodiola Pharmaceutical Holding Co Company Profile

Tibet Rhodiola Pharmaceutical Holding Co. manufactures pharmaceuticals in China and internationally. The company offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. It also provides capsules, biological preparations, granules, and film-coating agents for cardiovascular, cerebrovascular, hepatobiliary, sprains and contusions, rheumatism, rheumatoid arthritis, colds, and other fields. The company was founded in 1999 and is based in Lhasa, China.

Employees
596
Market
China

Compare 600211 to Peers and Sector

Metrics to compare
600211
Peers
Sector
Relationship
P/E Ratio
14.1x18.7x−0.6x
PEG Ratio
0.43−0.610.00
Price/Book
3.9x1.5x2.6x
Price / LTM Sales
5.1x1.3x3.4x
Upside (Analyst Target)
-19.5%44.4%
Fair Value Upside
Unlock18.2%6.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.04%
Dividend Yield
4.41%
Industry Median 1.45%
Annualized payout
1.87
Paid unevenly
5-Years Growth
+4.56%
Growth Streak

Earnings

Latest Release
Oct 31, 2025
EPS / Forecast
0.48 / --
Revenue / Forecast
438.57M / --
EPS Revisions
Last 90 days

600211 Income Statement

People Also Watch

73.00
603605
-0.67%
21.96
600285
+0.87%
83.97
605117
-2.77%
248.43
300394
+10.91%
40.63
603198
-4.69%

FAQ

What Is the Tibet Rhodiola Pharm (600211) Stock Price Today?

The Tibet Rhodiola Pharm stock price today is 42.40

What Stock Exchange Does Tibet Rhodiola Pharm Trade On?

Tibet Rhodiola Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Tibet Rhodiola Pharm?

The stock symbol for Tibet Rhodiola Pharm is "600211."

Does Tibet Rhodiola Pharm Pay Dividends? What’s The Current Dividend Yield?

The Tibet Rhodiola Pharm dividend yield is 4.41%.

What Is the Tibet Rhodiola Pharm Market Cap?

As of today, Tibet Rhodiola Pharm market cap is 13.66B.

What Is Tibet Rhodiola Pharm's Earnings Per Share (TTM)?

The Tibet Rhodiola Pharm EPS (TTM) is 3.04.

When Is the Next Tibet Rhodiola Pharm Earnings Date?

Tibet Rhodiola Pharm will release its next earnings report on Mar 13, 2026.

From a Technical Analysis Perspective, Is 600211 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Tibet Rhodiola Pharm Stock Split?

Tibet Rhodiola Pharm has split 4 times.

How Many Employees Does Tibet Rhodiola Pharm Have?

Tibet Rhodiola Pharm has 596 employees.

What is the current trading status of Tibet Rhodiola Pharm (600211)?

As of Jan 30, 2026, Tibet Rhodiola Pharm (600211) is trading at a price of 42.40, with a previous close of 42.80. The stock has fluctuated within a day range of 42.08 to 43.03, while its 52-week range spans from 34.60 to 57.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.